A hypothetical intervention on the use of hearing aids for the risk of dementia in people with hearing loss in UK Biobank

• by Jure Mur, Matthias Klee, Helen R Wright, Alina Solomon, Christine Johnson, Thomas J Littlejohns, Graciela Muniz-Terrera, Anja K Leist

• December 16, 2024

Explicit Mechanistic Causal Analyses or Interventional Trials Are Required for Objective, Clinical, Voice-Based Parkinson Disease Characterization

• by Max Little

• September 28, 2026

FDA approves gene therapy for MPS IIIA

The one-time intravenous treatment uses adeno-associated virus serotype 9 to deliver a functional copy of the SGSH gene.

• by Kathryn Wighton

• September 18, 2026

• 2 min

Specific treatment of ATTR-CM in Germany—expert consensus of the German Society of Amyloid Diseases (DGAK) and German Cardiac Society (DGK)

• by Fabian aus dem Siepen, Teresa Trenkwalder, Birgit Aßmus, Ingrid Kindermann, Daniel Lavall, Sebastian Spethmann, Lars Michel, Timon Hansen, Sebastian Kruck, Christoph Rischpler, Fabian Knebel, Stéphanie K. Schwarting, Udo Bavendiek, Maria Papathanasiou, Ute Hegenbart, Ali Yilmaz, Katrin Hahn, Alexander Carpinteiro, Roman Pfister, Caroline Morbach

• September 22, 2026